 |
|
Cost-effectiveness of Pharmaceutical Interventions to Prevent Osteoporotic Fractures in Postmenopausal Women with Osteopenia
Jin-Won Kwon, Hae-Young Park, Ye Jee Kim, Seong-Hwan Moon, Hye-Young Kang
J Bone Metab. 2016;23(2):63-77. Published online 2016 May 31 DOI: https://doi.org/10.11005/jbm.2016.23.2.63
|
|
Citations to this article as recorded by
 Cost-Effectiveness Analysis of Ultra-Hypofractionated Whole Breast Radiation Therapy Alone Versus Hormone Therapy Alone or Combined Treatment for Low-Risk ER-Positive Early Stage Breast Cancer in Women Aged 65 Years and Older
Matthew C. Ward, Abram Recht, Frank Vicini, Zahraa Al-Hilli, Wafa Asha, Manjeet Chadha, Abel Abraham, Nikhil Thaker, Atif J. Khan, Martin Keisch, Chirag Shah
International Journal of Radiation Oncology*Biology*Physics.2023; 116(3): 617. CrossRef Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV–DNA level < 2000 IU/mL
Hankil Lee, Sungin Jang, Sang Hoon Ahn, Beom Kyung Kim
Hepatology International.2022; 16(2): 294. CrossRef The Efficacy of Selective Estrogen Receptor Modulators Monotherapies in Postmenopausal Women with Osteopenia
Kyung Wook Kim, Young Il Kim, Ki-Choul Kim
Journal of Bone Metabolism.2022; 29(3): 185. CrossRef Economic impact of pharmaceutical interventions in a medium complexity Brazilian university hospital
Leandro Gouveia Carneiro, Karine Dal Paz, Eliane Ribeiro
Brazilian Journal of Pharmaceutical Sciences.2022;[Epub] CrossRef An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
Nannan Li, Dennis Cornelissen, Stuart Silverman, Daniel Pinto, Lei Si, Ingrid Kremer, Sandrine Bours, Robin de Bot, Annelies Boonen, Silvia Evers, Joop van den Bergh, Jean-Yves Reginster, Mickaël Hiligsmann
PharmacoEconomics.2021; 39(2): 181. CrossRef Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression
Hankil Lee, Beom Kyung Kim, Sungin Jang, Sang Hoon Ahn
Clinical and Translational Gastroenterology.2021; 12(2): e00299. CrossRef Cost-Effectiveness Analysis of No Adjuvant Therapy Versus Partial Breast Irradiation Alone Versus Combined Treatment for Treatment of Low-Risk DCIS: A Microsimulation
Matthew C. Ward, Frank Vicini, Zahraa Al-Hilli, Manjeet Chadha, Abel Abraham, Abram Recht, James Hayman, Nikhil Thaker, Atif J. Khan, Martin Keisch, Chirag Shah
JCO Oncology Practice.2021; 17(8): e1055. CrossRef Cost-effectiveness analysis of endocrine therapy alone versus partial-breast irradiation alone versus combined treatment for low-risk hormone-positive early-stage breast cancer in women aged 70 years or older
Matthew C. Ward, Frank Vicini, Zahraa Al-Hilli, Manjeet Chadha, Lori Pierce, Abram Recht, James Hayman, Nikhil Thaker, Atif J. Khan, Martin Keisch, Chirag Shah
Breast Cancer Research and Treatment.2020; 182(2): 355. CrossRef Estimating the Fiscal Costs of Osteoporosis in Korea Applying a Public Economic Perspective
Mark P. Connolly, Saswat Panda, Ha Young Kim
Journal of Bone Metabolism.2019; 26(4): 253. CrossRef Radiation Therapy Without Hormone Therapy for Women Age 70 or Above with Low-Risk Early Breast Cancer: A Microsimulation
Matthew C. Ward, Frank Vicini, Manjeet Chadha, Lori Pierce, Abram Recht, James Hayman, Nikhil G. Thaker, Atif Khan, Martin Keisch, Chirag Shah
International Journal of Radiation Oncology*Biology*Physics.2019; 105(2): 296. CrossRef Quality-Adjusted Life Years After Hip and Knee Arthroplasty
Joseph F. Konopka, Yuo-yu Lee, Edwin P. Su, Alexander S. McLawhorn
JBJS Open Access.2018; 3(3): e0007. CrossRef Health Economic Analysis of Antiplatelet Therapy for Acute Coronary Syndromes in the Context of Five Eastern Asian Countries
Bin Wu, Ruoyan Gai Tobe, Yuchen Liu, Ben He
Clinical Drug Investigation.2018; 38(7): 621. CrossRef
|